Synthetic biology is a branch of biological science that applies engineering principles to redesign organisms, endowing them with new functionalities. It can be viewed as the culmination or the deliberate, prescriptive stage of biology.
The primary product categories within synthetic biology include oligonucleotides, enzymes, cloning and assembly kits, xeno-nucleic acids (XNA), and chassis organisms. Oligonucleotides refer to small single-stranded DNA segments that, upon internalization by the cell, can selectively suppress the expression of a single protein. Various technologies, such as nucleotide synthesis and sequencing, bioinformatics, microfluidics, and genetic engineering, are employed in applications spanning pharmaceuticals and diagnostics, chemicals, biofuels, bioplastics, and other related fields.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The synthetic biology market research report is one of a series of new reports from The Business Research Company that provides synthetic biology market statistics, including synthetic biology industry global market size, regional shares, competitors with a synthetic biology market share, detailed synthetic biology market segments, market trends and opportunities, and any further data you may need to thrive in the synthetic biology industry. This synthetic biology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The synthetic biology market size has grown exponentially in recent years. It will grow from $21.13 billion in 2024 to $26.63 billion in 2025 at a compound annual growth rate (CAGR) of 26.0%. The growth in the historic period can be attributed to increasing healthcare and life science facilities, increasing investment in drug, wide application in end-user industries, low cost of dna sequencing and synthesizing, and rise in funding.
The synthetic biology market size is expected to see rapid growth in the next few years. It will grow to $53.83 billion in 2029 at a compound annual growth rate (CAGR) of 19.2%. The growth in the forecast period can be attributed to increasing government initiatives, demand for fuel alternatives, increase in demand for genetically modified crops, and increasing investments in private companies. Major trends in the forecast period include strategic collaborations and partnerships, automation in nucleotide synthesis and sequencing, rising focus on gene editing, product innovation rising adoption of cell-free technology, new environmentally friendly process for biofuel production.
The forecast of 19.2% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. biotech innovation by driving up the cost of gene synthesis kits and Deoxyribonucleic Acid assembly enzymes sourced from China and Singapore, stifling therapeutic development and increasing research laboratory overhead. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing investment in research and development (R&D) is expected to drive the growth of the synthetic biology market in the future. R&D involves the systematic investigation, experimentation, and innovation aimed at creating new knowledge, technologies, or products to enhance existing offerings or develop new ones. The rise in R&D investments is largely attributed to heightened competition, the demand for innovation, advancements in technology, and the necessity for businesses to adapt to evolving consumer preferences and market dynamics. Investment in R&D for synthetic biology is crucial for unlocking the field's potential to create sustainable solutions in healthcare, agriculture, and environmental management by engineering biological systems and organisms for specific applications. For example, in February 2024, a report from the Office for National Statistics, a UK-based government department, indicated that the pharmaceuticals product group was the top contributor to overall business R&D in the UK in 2022, accounting for $11.7 billion (£9.0 billion). This figure represented 17.9% of the total R&D conducted by UK businesses. Therefore, the increase in research and development investment is driving the growth of the synthetic biology market.
The rising demand for personalized medicine is poised to drive the growth of the synthetic biology market. Personalized medicine, also referred to as precision medicine, constitutes a category of medical treatments tailored to the specific characteristics of individual patients. Synthetic biology plays a crucial role in personalized medicine, offering potent tools and techniques to customize medical treatments and interventions based on an individual's distinct genetic and molecular profile. For instance, in 2023, the Personalized Medicine Coalition reported that in 2022, the FDA approved personalized medicines for 34% of new drugs. Over the previous eight years, these medicines were approved for at least 25% of new drugs. Thus, the escalating demand for personalized medicine emerges as a key driver for the growth of the synthetic biology market.
Recent technological advancements in DNA sequencing have empowered researchers to utilize DNA as a means to store non-genetic information. Given the escalating demand for data storage, DNA data storage presents a viable solution, with a single DNA strand capable of storing approximately 455 Exabytes of data (equivalent to 455 billion gigabytes). Consequently, this concept has attracted significant investments from market entities. Binary data, represented in 0s and 1s, is translated into DNA strings comprising four distinct base units-A, G, C, T (Adenine, Guanine, Cytosine, and Thymine). Notably, information encoded in DNA can endure for thousands of years, a remarkable contrast to traditional hard drives where data corruption or damage may occur within 30 years. For instance, a Nature Publishing Group journal reported that Microsoft and University of Washington researchers successfully stored over 200 megabytes of data, equivalent to 35 distinct digital files, in DNA. There are plans for increased investment to enhance this technology further.
Major companies active in the synthetic biology market are making strategic investments to drive innovation, research, and development in DNA synthesis technology. Investments in synthetic biology encompass financial backing and funding for companies and projects within this domain. In January 2022, Ribbon Biolabs GmbH, an Austrian biotechnology company, secured $19.12 million (approximately 18 million euros) in a series A funding round. This funding facilitated the establishment of commercial-scale manufacturing facilities and advancements in DNA synthesis technology in the United States. The potential outcomes include the development of new drugs, gene editing therapies, and personalized medicines, thereby improving the lives of numerous patients.
In July 2022, Ginkgo Bioworks, a US-based biotech company, completed the acquisition of Zymergen for $300 million. This strategic move is aimed at fortifying Ginkgo's platform, expanding its product portfolio, broadening its customer base, and achieving cost efficiencies. Zymergen, the acquired company, employs synthetic biology to create and manufacture various products, including materials, microbes, and therapeutics.
Major companies operating in the synthetic biology market include Thermo Fisher Scientific Inc, Danaher Corporation, Eurofins Scientific, Merck KGaA, Novozymes A/S, Agilent Technologies, New England Biolabs Inc, Precigen Inc, Amyris, Inc, Genscript Biotech Corporation, Codex Genetics, Cathay Biotech, Bota Biosciences, Bluepha, Spiber, OriCiro Genomics Inc, Provectus Algae, Puraffinity, Royal DSM NV, Colorifix, Phytoform Labs, Desktop Genetics, NanoSyrinx, Pulmobiotics S.L, EnginZyme, Chain Biotech, Nuclera Nucleics, Biosynthetics GmbH, Entelechon GmbH, Sloning BioTechnology GmbH, Prokarium Ltd, Synbio, Captor Therapeutics, Gero.ai, ARNA Genomics, Solvo Omixon, Soft flow, Algenol, Genomatica, Integrated DNA Technologies, Sana Biotechnology, Impossible Foods, Apeel Sciences, Twist Bioscience, Synlogic, Zymergen Inc, Ginkgo Bioworks, Codexis, Arzeda Corporation, Synthetic Genomics, Conagen, Dupont, Oxitec Ltd, Sentebiolab, GEEN Biotechnology Inc, Genbiotek Biosistem Laboratory Ltd
North America was the largest region in the synthetic biology market in 2024. Western Europe was the second largest region in the global synthetic biology market share. The regions covered in the synthetic biology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the synthetic biology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain
The synthetic biology market includes revenue earned by synthetic compound, technology and related services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Synthetic Biology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on synthetic biology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for synthetic biology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The synthetic biology market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Technology: Nucleotide Synthesis And Sequencing, Bioinformatics, Microfluidics, Genetic Engineering
- 3) By Product Type: Oligonucleotides, Enzymes, Cloning And Assembly Kits, Xeno-Nucleic Acids (XNA), Chassis Organism
- 2) By Application: Pharmaceuticals And Diagnostics, Chemicals, Biofuels, Bioplastics, Other Application
- Subsegments:
- 1) By Nucleotide Synthesis And Sequencing: DNA Synthesis Technologies; Next-Generation Sequencing (NGS); Sanger Sequencing
- 2) By Bioinformatics: Software Tools For Genomic Data Analysis; Databases For Gene/Protein Information; Algorithms For Gene Editing And Design
- 3) By Microfluidics: Lab-On-A-Chip Technologies; Microfluidic Devices For Biological Assays; Applications In Drug Discovery And Diagnostics
- 4) By Genetic Engineering: CRISPR/Cas9 Technology; Recombinant DNA Technology; Synthetic Gene Construction And Assembly
- Companies Mentioned: Thermo Fisher Scientific Inc; Danaher Corporation; Eurofins Scientific; Merck KGaA; Novozymes A/S; Agilent Technologies; New England Biolabs Inc; Precigen Inc; Amyris, Inc; Genscript Biotech Corporation; Codex Genetics; Cathay Biotech; Bota Biosciences; Bluepha; Spiber; OriCiro Genomics Inc; Provectus Algae; Puraffinity; Royal DSM NV; Colorifix; Phytoform Labs; Desktop Genetics; NanoSyrinx; Pulmobiotics S.L; EnginZyme; Chain Biotech; Nuclera Nucleics; Biosynthetics GmbH; Entelechon GmbH; Sloning BioTechnology GmbH; Prokarium Ltd; Synbio; Captor Therapeutics; Gero.ai; ARNA Genomics; Solvo Omixon; Soft flow; Algenol; Genomatica; Integrated DNA Technologies; Sana Biotechnology; Impossible Foods; Apeel Sciences; Twist Bioscience; Synlogic; Zymergen Inc; Ginkgo Bioworks; Codexis; Arzeda Corporation; Synthetic Genomics; Conagen; Dupont; Oxitec Ltd; Sentebiolab; GEEN Biotechnology Inc; Genbiotek Biosistem Laboratory Ltd
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Synthetic Biology Market Characteristics
3. Synthetic Biology Market Trends And Strategies
4. Synthetic Biology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Synthetic Biology Growth Analysis And Strategic Analysis Framework
- 5.1. Global Synthetic Biology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Synthetic Biology Market Growth Rate Analysis
- 5.4. Global Synthetic Biology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Synthetic Biology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Synthetic Biology Total Addressable Market (TAM)
6. Synthetic Biology Market Segmentation
- 6.1. Global Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Nucleotide Synthesis And Sequencing
- Bioinformatics
- Microfluidics
- Genetic Engineering
- 6.2. Global Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oligonucleotides
- Enzymes
- Cloning and Assembly Kits
- Xeno-nucleic Acids (XNA)
- Chassis Organism
- 6.3. Global Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pharmaceuticals And Diagnostics
- Chemicals
- Biofuels
- Bioplastics
- Other Applications
- 6.4. Global Synthetic Biology Market, Sub-Segmentation Of Nucleotide Synthesis And Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- DNA Synthesis Technologies
- Next-Generation Sequencing (NGS)
- Sanger Sequencing
- 6.5. Global Synthetic Biology Market, Sub-Segmentation Of Bioinformatics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Software Tools For Genomic Data Analysis
- Databases For Gene/Protein Information
- Algorithms For Gene Editing And Design
- 6.6. Global Synthetic Biology Market, Sub-Segmentation Of Microfluidics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Lab-On-A-Chip Technologies
- Microfluidic Devices For Biological Assays
- Applications In Drug Discovery And Diagnostics
- 6.7. Global Synthetic Biology Market, Sub-Segmentation Of Genetic Engineering, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- CRISPR/Cas9 Technology
- Recombinant DNA Technology
- Synthetic Gene Construction And Assembly
7. Synthetic Biology Market Regional And Country Analysis
- 7.1. Global Synthetic Biology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Synthetic Biology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Synthetic Biology Market
- 8.1. Asia-Pacific Synthetic Biology Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Synthetic Biology Market
- 9.1. China Synthetic Biology Market Overview
- 9.2. China Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Synthetic Biology Market
- 10.1. India Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Synthetic Biology Market
- 11.1. Japan Synthetic Biology Market Overview
- 11.2. Japan Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Synthetic Biology Market
- 12.1. Australia Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Synthetic Biology Market
- 13.1. Indonesia Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Synthetic Biology Market
- 14.1. South Korea Synthetic Biology Market Overview
- 14.2. South Korea Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Synthetic Biology Market
- 15.1. Western Europe Synthetic Biology Market Overview
- 15.2. Western Europe Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Synthetic Biology Market
- 16.1. UK Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Synthetic Biology Market
- 17.1. Germany Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Synthetic Biology Market
- 18.1. France Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Synthetic Biology Market
- 19.1. Italy Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Synthetic Biology Market
- 20.1. Spain Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Synthetic Biology Market
- 21.1. Eastern Europe Synthetic Biology Market Overview
- 21.2. Eastern Europe Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Synthetic Biology Market
- 22.1. Russia Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Synthetic Biology Market
- 23.1. North America Synthetic Biology Market Overview
- 23.2. North America Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Synthetic Biology Market
- 24.1. USA Synthetic Biology Market Overview
- 24.2. USA Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Synthetic Biology Market
- 25.1. Canada Synthetic Biology Market Overview
- 25.2. Canada Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Synthetic Biology Market
- 26.1. South America Synthetic Biology Market Overview
- 26.2. South America Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Synthetic Biology Market
- 27.1. Brazil Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Synthetic Biology Market
- 28.1. Middle East Synthetic Biology Market Overview
- 28.2. Middle East Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Synthetic Biology Market
- 29.1. Africa Synthetic Biology Market Overview
- 29.2. Africa Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Synthetic Biology Market Competitive Landscape And Company Profiles
- 30.1. Synthetic Biology Market Competitive Landscape
- 30.2. Synthetic Biology Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Novozymes A/S Overview, Products and Services, Strategy and Financial Analysis
31. Synthetic Biology Market Other Major And Innovative Companies
- 31.1. Agilent Technologies
- 31.2. New England Biolabs Inc
- 31.3. Precigen Inc
- 31.4. Amyris, Inc
- 31.5. Genscript Biotech Corporation
- 31.6. Codex Genetics
- 31.7. Cathay Biotech
- 31.8. Bota Biosciences
- 31.9. Bluepha
- 31.10. Spiber
- 31.11. OriCiro Genomics Inc
- 31.12. Provectus Algae
- 31.13. Puraffinity
- 31.14. Royal DSM NV
- 31.15. Colorifix
32. Global Synthetic Biology Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Synthetic Biology Market
34. Recent Developments In The Synthetic Biology Market
35. Synthetic Biology Market High Potential Countries, Segments and Strategies
- 35.1 Synthetic Biology Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Synthetic Biology Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Synthetic Biology Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
